Ana María
Zubiaga Elordieta
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (5)
2021
-
E2F1 and E2F2-mediated repression of CPT2 establishes a lipid-rich tumor-promoting environment
Cancer Research, Vol. 81, Núm. 11, pp. 2874-2887
2009
-
Microarray analysis of autoimmune diseases by machine learning procedures
IEEE Transactions on Information Technology in Biomedicine, Vol. 13, Núm. 3, pp. 341-350
2008
-
Innate immune response gene expression profiles characterize primary antiphospholipid syndrome
Genes and Immunity, Vol. 9, Núm. 1, pp. 38-46
2006
-
Transcriptional activation of the proapoptotic bik gene by E2F proteins in cancer cells
FEBS Letters, Vol. 580, Núm. 25, pp. 5905-5909
2005
-
E2F1-/- C57BL/6 mice overexpressing a human Bcl-2 transgene in B cells develop a mild autoimmune syndrome
Annals of the New York Academy of Sciences